enVVeno Medical Corporation
NVNO
$10.33
$0.333.30%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -11.72% | -8.28% | -2.43% | 10.96% | 5.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.34% | -13.54% | -1.94% | 6.03% | -2.79% |
| Operating Income | 15.34% | 13.54% | 1.94% | -6.03% | 2.79% |
| Income Before Tax | 11.78% | 10.76% | -3.42% | -11.99% | 3.55% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 11.78% | 10.76% | -3.42% | -11.99% | 3.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.78% | 10.76% | -3.42% | -11.99% | 3.55% |
| EBIT | 15.34% | 13.54% | 1.94% | -6.03% | 2.79% |
| EBITDA | 15.25% | 13.43% | 1.71% | -6.36% | 2.61% |
| EPS Basic | 24.53% | 25.65% | 19.03% | 15.55% | 34.24% |
| Normalized Basic EPS | 27.95% | 29.42% | 24.85% | 21.01% | 34.33% |
| EPS Diluted | 24.53% | 25.65% | 19.03% | 15.55% | 34.24% |
| Normalized Diluted EPS | 27.95% | 29.42% | 24.85% | 21.01% | 34.33% |
| Average Basic Shares Outstanding | 16.63% | 20.17% | 27.55% | 31.08% | 39.43% |
| Average Diluted Shares Outstanding | 16.63% | 20.17% | 27.55% | 31.08% | 39.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |